The Effect of Intravenous (IV) Patient Controlled Analgesic (PCA) With Ketorolac or Fentanyl Combined With Caudal Block for Postoperative Analgesia in Small Children Undergoing Intravesical Ureteroneocystostomy

NCT ID: NCT01081535

Last Updated: 2010-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-05-31

Study Completion Date

2010-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The effect of IV PCA with ketorolac or fentanyl combined with caudal block for postoperative analgesia in small children undergoing intravesical ureteroneocystostomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ureteroneocystostomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ketorolac

Group Type EXPERIMENTAL

ketorolac, fentanyl

Intervention Type DRUG

intravenous PCA

fentanyl

Group Type EXPERIMENTAL

ketorolac, fentanyl

Intervention Type DRUG

intravenous PCA

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ketorolac, fentanyl

intravenous PCA

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pediatric patients scheduled for elective ureteroneocystostomy were enrolled.

Exclusion Criteria

* History of allergy to aspirin or NSAIDs
* Peptic ulcer disease, and renal function impairment.
* And local infection foci on back, spinal anomalies
* Infectious diseases
* Neurologic disorders
* Seizures and coagulopathies were excluded for sacral epidural block.
Minimum Eligible Age

6 Months

Maximum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yonsei University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yonsei University, College of Medicine

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hae Keum Kil

Role: PRINCIPAL_INVESTIGATOR

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4-2009-0107

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.